233 related articles for article (PubMed ID: 26093509)
21. Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragment.
Broders O; Wessels U; Zadak M; Beckmann R; Stubenrauch K
Bioanalysis; 2020 Apr; 12(8):509-517. PubMed ID: 32351119
[No Abstract] [Full Text] [Related]
22. Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumab.
Mojtahed Poor S; Ulshöfer T; Gabriel LA; Henke M; Köhm M; Behrens F; Geisslinger G; Parnham MJ; Burkhardt H; Schiffmann S
Clin Exp Immunol; 2019 May; 196(2):259-275. PubMed ID: 30656642
[TBL] [Abstract][Full Text] [Related]
23. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
Smith HW; Butterfield A; Sun D
Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
[TBL] [Abstract][Full Text] [Related]
24. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
Liu Y; Reidler H; Pan J; Milunic D; Qin D; Chen D; Vallejo YR; Yin R
J Pharmacol Toxicol Methods; 2011; 64(3):238-45. PubMed ID: 21827863
[TBL] [Abstract][Full Text] [Related]
25. Mitigation of Pre-existing Antibodies to a Biotherapeutic in Non-clinical Species When Establishing Anti-drug Antibody Assay Cutpoint.
Kumar SC; DelCarpini JA; Qu Q; Kane M; Gorovits B
AAPS J; 2017 Jan; 19(1):313-319. PubMed ID: 27873117
[TBL] [Abstract][Full Text] [Related]
26. Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics.
Gorovits B; Peng K; Kromminga A
BioDrugs; 2020 Feb; 34(1):39-54. PubMed ID: 31641991
[TBL] [Abstract][Full Text] [Related]
27. Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys.
Choi WH; Jo HR; Jeon EJ; Youm SY; Jeon JS; Son YG; You WK; Koh WS; Lee SH; Kim SK
J Pharm Biomed Anal; 2016 Nov; 131():309-315. PubMed ID: 27619177
[TBL] [Abstract][Full Text] [Related]
28. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
29. A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties.
Winter J; Barbin K; Bacci C; Bunte T
J Pharm Biomed Anal; 2011 Jan; 54(1):81-6. PubMed ID: 20828971
[TBL] [Abstract][Full Text] [Related]
30. Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.
van Brummelen EM; Ros W; Wolbink G; Beijnen JH; Schellens JH
Oncologist; 2016 Oct; 21(10):1260-1268. PubMed ID: 27440064
[TBL] [Abstract][Full Text] [Related]
31. Dose levels in particulate-containing formulations impact anti-drug antibody responses to murine monoclonal antibody in mice.
Shomali M; Tanriverdi S; Freitag AJ; Engert J; Winter G; Siedler M; Kaymakcalan Z; Carpenter JF; Randolph TW
J Pharm Sci; 2015 May; 104(5):1610-21. PubMed ID: 25737325
[TBL] [Abstract][Full Text] [Related]
32. Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses.
Chin SE; Ferraro F; Groves M; Liang M; Vaughan TJ; Dobson CL
J Immunol Methods; 2015 Jan; 416():49-58. PubMed ID: 25449532
[TBL] [Abstract][Full Text] [Related]
33. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of an anti-rituximab monoclonal antibody panel.
Tada M; Suzuki T; Ishii-Watabe A
MAbs; 2018 Apr; 10(3):370-379. PubMed ID: 29309213
[TBL] [Abstract][Full Text] [Related]
35. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
Xu W; Jiang H; Titsch C; Haulenbeek JR; Pillutla RC; Aubry AF; DeSilva BS; Arnold ME; Zeng J; Dodge RW
J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testing.
Rispens T; de Vrieze H; de Groot E; Wouters D; Stapel S; Wolbink GJ; Aarden LA
J Immunol Methods; 2012 Jan; 375(1-2):93-9. PubMed ID: 21986105
[TBL] [Abstract][Full Text] [Related]
38. A simple and cost-effective assay for measuring anti-drug antibody in human patients treated with Adalimumab.
Li M; Li H; Gao K; Wang M; An W; Zhu Y; Ding L; Wang L; Gu J; Zuo C; Sun L
J Immunol Methods; 2018 Jan; 452():6-11. PubMed ID: 29037956
[TBL] [Abstract][Full Text] [Related]
39. T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.
Jawa V; Cousens LP; Awwad M; Wakshull E; Kropshofer H; De Groot AS
Clin Immunol; 2013 Dec; 149(3):534-55. PubMed ID: 24263283
[TBL] [Abstract][Full Text] [Related]
40. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
